Physician profile
Carissa Meyer
NPI 1831324227
$897.45
in general payments reported to CMS, 2019-2025
9 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $61.32 · 2023: $214 · 2024: $156 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $265.49 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Stryker Corporation | $216.18 | 2019-2025 | Gamma, Conextions Tr Tendon Repair System-Implant Mechanism |
| Endo USA, INC. | $200.01 | 2024-2025 | Xiaflex |
| Seapearl East, INC | $79.81 | 2025 | |
| Depuy Synthes Sales INC. | $44.34 | 2020 | |
| Endo Pharmaceuticals INC. | $28.47 | 2019 | |
| Boston Scientific Corporation | $26.37 | 2019 | |
| Ethicon US, LLC | $19.80 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix, Dermabond Prineo |
| Orthogenrx INC. | $16.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.